111 related articles for article (PubMed ID: 22728768)
1. Expression of a versatile DC-targeting fusion protein using an Adenovirus expression system.
Pillay S; Patterson S
Protein Expr Purif; 2012 Aug; 84(2):270-9. PubMed ID: 22728768
[TBL] [Abstract][Full Text] [Related]
2. Complexes of streptavidin-fused antigens with biotinylated antibodies targeting receptors on dendritic cell surface: a novel tool for induction of specific T-cell immune responses.
Stanek O; Linhartova I; Majlessi L; Leclerc C; Sebo P
Mol Biotechnol; 2012 Jul; 51(3):221-32. PubMed ID: 22006508
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.
Grossmann C; Tenbusch M; Nchinda G; Temchura V; Nabi G; Stone GW; Kornbluth RS; Uberla K
BMC Immunol; 2009 Aug; 10():43. PubMed ID: 19650904
[TBL] [Abstract][Full Text] [Related]
4. Targeting antigen in mature dendritic cells for simultaneous stimulation of CD4+ and CD8+ T cells.
Bonini C; Lee SP; Riddell SR; Greenberg PD
J Immunol; 2001 Apr; 166(8):5250-7. PubMed ID: 11290810
[TBL] [Abstract][Full Text] [Related]
5. Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8α+ dendritic cell subset.
Suleman M; Galea S; Gavard F; Merillon N; Klonjkowski B; Tartour E; Richardson J
Vaccine; 2011 Aug; 29(35):5892-903. PubMed ID: 21723900
[TBL] [Abstract][Full Text] [Related]
6. Myeloid and plasmacytoid dendritic cells are susceptible to recombinant adenovirus vectors and stimulate polyfunctional memory T cell responses.
Loré K; Adams WC; Havenga MJ; Precopio ML; Holterman L; Goudsmit J; Koup RA
J Immunol; 2007 Aug; 179(3):1721-9. PubMed ID: 17641038
[TBL] [Abstract][Full Text] [Related]
7. Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses.
Chmielewska AM; Naddeo M; Capone S; Ammendola V; Hu K; Meredith L; Verhoye L; Rychlowska M; Rappuoli R; Ulmer JB; Colloca S; Nicosia A; Cortese R; Leroux-Roels G; Balfe P; Bienkowska-Szewczyk K; Meuleman P; McKeating JA; Folgori A
J Virol; 2014 May; 88(10):5502-10. PubMed ID: 24599994
[TBL] [Abstract][Full Text] [Related]
8. Enhanced transduction of dendritic cells by FcgammaRI-targeted adenovirus vectors.
Sapinoro R; Maguire CA; Burgess A; Dewhurst S
J Gene Med; 2007 Dec; 9(12):1033-45. PubMed ID: 17966114
[TBL] [Abstract][Full Text] [Related]
9. Coexpression of GM-CSF and antigen in DNA prime-adenoviral vector boost immunization enhances polyfunctional CD8+ T cell responses, whereas expression of GM-CSF antigen fusion protein induces autoimmunity.
Tenbusch M; Kuate S; Tippler B; Gerlach N; Schimmer S; Dittmer U; Uberla K
BMC Immunol; 2008 Apr; 9():13. PubMed ID: 18405363
[TBL] [Abstract][Full Text] [Related]
10. Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity.
Tsuji T; Matsuzaki J; Kelly MP; Ramakrishna V; Vitale L; He LZ; Keler T; Odunsi K; Old LJ; Ritter G; Gnjatic S
J Immunol; 2011 Jan; 186(2):1218-27. PubMed ID: 21149605
[TBL] [Abstract][Full Text] [Related]
11. Targeting the antigen encoded by adenoviral vectors to the DEC205 receptor modulates the cellular and humoral immune response.
Tenbusch M; Nchinda G; Storcksdieck genannt Bonsmann M; Temchura V; Überla K
Int Immunol; 2013 Apr; 25(4):247-58. PubMed ID: 23184617
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of DNA vaccination with recombinant adenoviruses using bioluminescence imaging of antigen expression: impact of application routes and delivery with dendritic cells.
Schweichel D; Steitz J; Tormo D; Gaffal E; Ferrer A; Büchs S; Speuser P; Limmer A; Tüting T
J Gene Med; 2006 Oct; 8(10):1243-50. PubMed ID: 16892456
[TBL] [Abstract][Full Text] [Related]
13. Fusion of Bacterial Flagellin to a Dendritic Cell-Targeting αCD40 Antibody Construct Coupled With Viral or Leukemia-Specific Antigens Enhances Dendritic Cell Maturation and Activates Peptide-Responsive T Cells.
Schmitt S; Tahk S; Lohner A; Hänel G; Maiser A; Hauke M; Patel L; Rothe M; Josenhans C; Leonhardt H; Griffioen M; Deiser K; Fenn NC; Hopfner KP; Subklewe M
Front Immunol; 2020; 11():602802. PubMed ID: 33281829
[TBL] [Abstract][Full Text] [Related]
14. Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8(+) T cell response: a comparative study.
Cruz LJ; Rosalia RA; Kleinovink JW; Rueda F; Löwik CW; Ossendorp F
J Control Release; 2014 Oct; 192():209-18. PubMed ID: 25068703
[TBL] [Abstract][Full Text] [Related]
15. Targeting dendritic cells in humanized mice receiving adoptive T cells via monoclonal antibodies fused to Flu epitopes.
Graham JP; Authie P; Yu CI; Zurawski SM; Li XH; Marches F; Flamar AL; Acharya A; Banchereau J; Palucka AK
Vaccine; 2016 Sep; 34(41):4857-4865. PubMed ID: 27595442
[TBL] [Abstract][Full Text] [Related]
16. Heterologous prime-boost regimens with a recombinant chimpanzee adenoviral vector and adjuvanted F4 protein elicit polyfunctional HIV-1-specific T-Cell responses in macaques.
Lorin C; Vanloubbeeck Y; Baudart S; Ska M; Bayat B; Brauers G; Clarinval G; Donner MN; Marchand M; Koutsoukos M; Mettens P; Cohen J; Voss G
PLoS One; 2015; 10(4):e0122835. PubMed ID: 25856308
[TBL] [Abstract][Full Text] [Related]
17. Immediate-early expression of a recombinant antigen by modified vaccinia virus ankara breaks the immunodominance of strong vector-specific B8R antigen in acute and memory CD8 T-cell responses.
Baur K; Brinkmann K; Schweneker M; Pätzold J; Meisinger-Henschel C; Hermann J; Steigerwald R; Chaplin P; Suter M; Hausmann J
J Virol; 2010 Sep; 84(17):8743-52. PubMed ID: 20538860
[TBL] [Abstract][Full Text] [Related]
18. Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation.
van Kooyk Y; Unger WW; Fehres CM; Kalay H; García-Vallejo JJ
Mol Immunol; 2013 Sep; 55(2):143-5. PubMed ID: 23158834
[TBL] [Abstract][Full Text] [Related]
19. In vivo targeting of porcine reproductive and respiratory syndrome virus antigen through porcine DC-SIGN to dendritic cells elicits antigen-specific CD4T cell immunity in pigs.
Subramaniam S; Piñeyro P; Tian D; Overend C; Yugo DM; Matzinger SR; Rogers AJ; Haac ME; Cao Q; Heffron CL; Catanzaro N; Kenney SP; Huang YW; Opriessnig T; Meng XJ
Vaccine; 2014 Nov; 32(50):6768-75. PubMed ID: 25446829
[TBL] [Abstract][Full Text] [Related]
20. A versatile bifunctional dendritic cell targeting vaccine vector.
Wang WW; Das D; Suresh MR
Mol Pharm; 2009; 6(1):158-72. PubMed ID: 19053535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
